18F−Prostate−Specific Membrane Antigen PET/CT imaging for potentially resectable pancreatic cancer (PANSCAN−2): a phase I/II study

Abstract Background Current diagnostic imaging modalities have limited ability to differentiate between malignant and benign pancreaticobiliary disease, and lack accuracy in detecting lymph node metastases. 18F-Prostate-Specific Membrane Antigen (PSMA) PET/CT is an imaging modality used for staging...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Jisce R. Puik, Thomas T. Poels, Gerrit K. J. Hooijer, Matthijs C. F. Cysouw, Joanne Verheij, Johanna W. Wilmink, Elisa Giovannetti, Geert Kazemier, Arantza Farina Sarasqueta, Daniela E. Oprea-Lager, Rutger-Jan Swijnenburg
Format:	Artigo
Jezik:	Inglês
Izdano:	BMC 2025-01-01
Serija:	Cancer Imaging
Teme:	PSMA PET/CT PDAC Pancreatic cancer Diagnosis
Online dostop:	https://doi.org/10.1186/s40644-025-00822-y
Oznake:	Označite Brez oznak, prvi označite!